[The role of Agreal in the treatment of the menopause].
The treatment of menopause comprises two phases: on the one hand, the curative treatment of the premature climateric syndrome, including a case by case discussion of the value of a hormonal or non-hormonal treatment; on the other hand, the preventive treatment of delayed deficiency, for which only opotherapy, using estrogens and progestatives, is indicated. The therapeutic choice is guided, in the first case, by the existence or non-existence of an objective counter-indication to the use of estrogens or of reticence on the part of the patient to the use of a hormonal treatment. In the second case, the decision is based only on the benefit/risk ratio, and estrogeno-therapy, in the opinion of many, should be reserved for women in whom estrogen deficiency has been demonstrated. Veralipride (Agreal) is, medically speaking, a non-hormonal drug, and has a proven efficacy in vasomotor heat flushes and the psychofunctional signs of confirmed menopause. It is well tolerated and is easy to use.
D000328:Adult; D002979:Climacteric / Q000187:drug effects*; D004341:Drug Evaluation; D004967:Estrogens / Q000009:adverse effects / Q000172:deficiency / Q000627:therapeutic use*; D005260:Female; D005483:Flushing / Q000503:physiopathology / Q000628:therapy; D006801:Humans; D008593:Menopause / Q000187:drug effects*; D008875:Middle Aged; D011602:Psychophysiologic Disorders / Q000188:drug therapy; D013469:Sulpiride / Q000031:analogs & derivatives* / Q000627:therapeutic use
D004967:Estrogens; D013469:Sulpiride; C027429:veralipride
Place de l'Agréal dans le traitement de la ménopause.